Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D ...

For each region and country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of all regional markets by country and the breakdown of each national market by ...

as high temperatures kill the virus. The CDC has created two candidate vaccines for the H5N1 bird flu and shared them with vaccine manufacturers. If there's an outbreak or pandemic, the ...

The organisation is working with nations worldwide to coordinate accelerated vaccine access and containment measures. They say an initial sum of $15m (£12m) will be required for an effective ...

The incidence of chickenpox has declined with widespread use of live-attenuated varicella vaccine in infants (Journal Watch Feb 22 2002). To assess the vaccine's effectiveness, researchers ...

The current wave of scepticism is the latest rekindling of an angry debate going back to the dawn of vaccination in 1796 when Edward Jenner created the smallpox vaccine. In the 1890s huge crowds ...

You don’t need the vaccine if you’ve already had chickenpox, since having the disease gives you lifelong immunity. But the virus can return as shingles, for which a separate vaccine is available.

NAIROBI, Jan 15 (Reuters) - A suspected outbreak of the Marburg virus in northwest Tanzania has infected nine people, killing eight of them, the World Health Organization has said, weeks after an ...

Babies are supposed to receive vaccines that protect against about 15 different infectious diseases. Most require more than one dose, which amounts to nearly 30 jabs by age two. Parents may be ...

Moderna is recruiting adult participants for Nova 301, its Phase 3 clinical trial evaluating an investigational norovirus vaccine called mRNA-1403.